Cargando…

Was the internal thoracic arterial graft selection for coronary artery bypass grafting appropriate in a patient with neurofibromatosis-1?

Neurofibromatosis type 1, also called von Recklinghausen’s disease, is a hereditary congenital disorder that affects tissues of neuroectodermal or mesodermal origin. This disease has various manifestations, including pigmented skin lesions, cutaneous neurofibromas, skeletal abnormalities, and tumors...

Descripción completa

Detalles Bibliográficos
Autores principales: Nakayama, Taisuke, Nakayama, Mayuko, Harada, Takashi, Isshiki, Shingo, Sasaki, Hideki, Ishitoya, Hiroshi
Formato: Online Artículo Texto
Lenguaje:English
Publicado: SAGE Publications 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349987/
https://www.ncbi.nlm.nih.gov/pubmed/30719296
http://dx.doi.org/10.1177/2050313X18818724
_version_ 1783390364391964672
author Nakayama, Taisuke
Nakayama, Mayuko
Harada, Takashi
Isshiki, Shingo
Sasaki, Hideki
Ishitoya, Hiroshi
author_facet Nakayama, Taisuke
Nakayama, Mayuko
Harada, Takashi
Isshiki, Shingo
Sasaki, Hideki
Ishitoya, Hiroshi
author_sort Nakayama, Taisuke
collection PubMed
description Neurofibromatosis type 1, also called von Recklinghausen’s disease, is a hereditary congenital disorder that affects tissues of neuroectodermal or mesodermal origin. This disease has various manifestations, including pigmented skin lesions, cutaneous neurofibromas, skeletal abnormalities, and tumors of the central/peripheral nervous and gastrointestinal systems, and vascular abnormalities. Because of vasculopathy, part of the vessel wall may be replaced by neurofibromatosis tissue. Involvement of the internal thoracic artery is, however, extremely rare. Off-pump coronary artery bypass grafting using the left internal thoracic artery was performed for coronary arterial disease in a patient with neurofibromatosis, and the residual left internal thoracic artery vessel pathology was investigated. The left internal thoracic artery vessel showed intimal proliferation, medial thinning, and fragmentation of elastic tissue. However, these findings were not typical for von Recklinghausen’s neurofibromatosis. Internal thoracic artery graft selection was feasible for coronary artery bypass grafting in a patient with neurofibromatosis type 1.
format Online
Article
Text
id pubmed-6349987
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher SAGE Publications
record_format MEDLINE/PubMed
spelling pubmed-63499872019-02-04 Was the internal thoracic arterial graft selection for coronary artery bypass grafting appropriate in a patient with neurofibromatosis-1? Nakayama, Taisuke Nakayama, Mayuko Harada, Takashi Isshiki, Shingo Sasaki, Hideki Ishitoya, Hiroshi SAGE Open Med Case Rep Case Report Neurofibromatosis type 1, also called von Recklinghausen’s disease, is a hereditary congenital disorder that affects tissues of neuroectodermal or mesodermal origin. This disease has various manifestations, including pigmented skin lesions, cutaneous neurofibromas, skeletal abnormalities, and tumors of the central/peripheral nervous and gastrointestinal systems, and vascular abnormalities. Because of vasculopathy, part of the vessel wall may be replaced by neurofibromatosis tissue. Involvement of the internal thoracic artery is, however, extremely rare. Off-pump coronary artery bypass grafting using the left internal thoracic artery was performed for coronary arterial disease in a patient with neurofibromatosis, and the residual left internal thoracic artery vessel pathology was investigated. The left internal thoracic artery vessel showed intimal proliferation, medial thinning, and fragmentation of elastic tissue. However, these findings were not typical for von Recklinghausen’s neurofibromatosis. Internal thoracic artery graft selection was feasible for coronary artery bypass grafting in a patient with neurofibromatosis type 1. SAGE Publications 2019-01-22 /pmc/articles/PMC6349987/ /pubmed/30719296 http://dx.doi.org/10.1177/2050313X18818724 Text en © The Author(s) 2019 http://www.creativecommons.org/licenses/by-nc/4.0/ This article is distributed under the terms of the Creative Commons Attribution-NonCommercial 4.0 License (http://www.creativecommons.org/licenses/by-nc/4.0/) which permits non-commercial use, reproduction and distribution of the work without further permission provided the original work is attributed as specified on the SAGE and Open Access pages (https://us.sagepub.com/en-us/nam/open-access-at-sage).
spellingShingle Case Report
Nakayama, Taisuke
Nakayama, Mayuko
Harada, Takashi
Isshiki, Shingo
Sasaki, Hideki
Ishitoya, Hiroshi
Was the internal thoracic arterial graft selection for coronary artery bypass grafting appropriate in a patient with neurofibromatosis-1?
title Was the internal thoracic arterial graft selection for coronary artery bypass grafting appropriate in a patient with neurofibromatosis-1?
title_full Was the internal thoracic arterial graft selection for coronary artery bypass grafting appropriate in a patient with neurofibromatosis-1?
title_fullStr Was the internal thoracic arterial graft selection for coronary artery bypass grafting appropriate in a patient with neurofibromatosis-1?
title_full_unstemmed Was the internal thoracic arterial graft selection for coronary artery bypass grafting appropriate in a patient with neurofibromatosis-1?
title_short Was the internal thoracic arterial graft selection for coronary artery bypass grafting appropriate in a patient with neurofibromatosis-1?
title_sort was the internal thoracic arterial graft selection for coronary artery bypass grafting appropriate in a patient with neurofibromatosis-1?
topic Case Report
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6349987/
https://www.ncbi.nlm.nih.gov/pubmed/30719296
http://dx.doi.org/10.1177/2050313X18818724
work_keys_str_mv AT nakayamataisuke wastheinternalthoracicarterialgraftselectionforcoronaryarterybypassgraftingappropriateinapatientwithneurofibromatosis1
AT nakayamamayuko wastheinternalthoracicarterialgraftselectionforcoronaryarterybypassgraftingappropriateinapatientwithneurofibromatosis1
AT haradatakashi wastheinternalthoracicarterialgraftselectionforcoronaryarterybypassgraftingappropriateinapatientwithneurofibromatosis1
AT isshikishingo wastheinternalthoracicarterialgraftselectionforcoronaryarterybypassgraftingappropriateinapatientwithneurofibromatosis1
AT sasakihideki wastheinternalthoracicarterialgraftselectionforcoronaryarterybypassgraftingappropriateinapatientwithneurofibromatosis1
AT ishitoyahiroshi wastheinternalthoracicarterialgraftselectionforcoronaryarterybypassgraftingappropriateinapatientwithneurofibromatosis1